While multi-omics imaging, combining PSMA, glucose metabolism, and tumor microenvironmental markers, could potentially enhance the characterization of PCa heterogeneity, its practical implementation in a single imaging examination remains challenging. This evidence concerns the gene FOLH1 and neoplasm.